Home » Authors » Don Long

Articles by Don Long

Bone scan detecting metabolic changes is better knee OA test

April 1, 2004

Cepheid Raising $62M Through Public Offering Of 5.5M Shares

Feb. 13, 2004

Cepheid Raising $62M Through Public Offering Of 5.5M Shares

Feb. 13, 2004

CryoLife Privately Raises $20M, Calls Near Term 'Very Promising'

Jan. 27, 2004

CryoLife Privately Raises $20M, Calls Near Term 'Very Promising'

Jan. 27, 2004

Earlier discovery of lung cancer key focus of new tech roll-outs

Jan. 1, 2004

Optimizer II seeks a niche in weaponry against heart failure

Dec. 1, 2003

Vitex Halts Phase III Chronic Trial Of Inactine, Seeks New Financing

Nov. 19, 2003

Vitex Halts Phase III Chronic Trial Of Inactine, Seeks New Financing

Nov. 19, 2003

Still Focused On Intercept, Cerus Cuts Work Force By 25 Percent

Oct. 17, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 3, 2026.
ASCO 2026: A revolution in pancreatic cancer
BioWorld
At the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting, Revolution Medicines Inc. followed up its stellar top-line data with the details from the...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 2, 2026
EASL 2026: Emerging liver disease targets to watch
BioWorld
At the recently concluded European Association for the Study of the Liver meeting, presentations underscored how increasingly granular insights into liver...
ASCO 2026: PD-(L)1 x VEGF bispecifics fight it out
BioWorld
Multiple companies are chasing Akeso Inc. and Summit Therapeutics Inc. in the battle to potentially dethrone Keytruda (pembrolizumab, Merck & Co. Inc.) as the top...